Axiom Investment Management LLC

Position in JNJ — Johnson & Johnson

CIK 1513703 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,010,288

+$73,599 QoQ

Shares Held

3,978

+3.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

#3,010

of 4,676 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Axiom Investment Management LLC holds $9,628,805 across 10 Drug Manufacturers - General names. JNJ ranks #5 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	86,053	$2,072,142
2	LLY	ELI LILLY & Co	1,400	$1,679,191
3	BMY	Bristol Myers Squibb Co	23,292	$1,342,081
4	ABBV	AbbVie Inc.	4,806	$1,209,381
5	JNJ	Johnson & Johnson This page	3,978	$1,010,288
6	MRK	Merck & Co., Inc.	6,417	$824,580
7	GILD	Gilead Sciences, Inc.	6,343	$801,374
8	NVS	Novartis AG	3,326	$521,249

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,010,288	3,978	+3.8%	Shares	Sole	2026-07-31
2026-03-31	$936,689	3,832	+36.8%	Shares	Sole	2026-05-26
2022-12-31	$494,785	2,801	+3.9%	Shares	Sole	2023-02-14
2022-09-30	$440,571	2,697	+0.0%	Shares	Sole	2022-11-14
2022-06-30	$478,555	2,696	-2.0%	Shares	Sole	2022-08-15
2022-03-31	$487,372	2,750	-18.3%	Shares	Sole	2022-05-13
2021-12-31	$575,977	3,367	+0.3%	Shares	Sole	2022-02-02
2021-09-30	$541,986	3,356	-0.0%	Shares	Sole	2021-10-18
2021-06-30	$553,017	3,357	-1.2%	Shares	Sole	2021-08-16
2021-03-31	$558,610	3,399	-47.2%	Shares	Sole	2021-05-20
2020-12-31	$991,320	6,437	+32.6%	Shares	Sole	2021-02-11
2020-09-30	$722,943	4,856	-3.1%	Shares	Sole	2021-03-16
2020-06-30	$704,399	5,009	+9.7%	Shares	Sole	2021-03-16
2020-03-31	$598,855	4,567	—	Shares	Sole	2021-03-16
No filing history on record for this holder in this stock.